Primary biliary cirrhosis - Presentation and diagnosis

Clinics in Liver Disease

Volumn 7, Issue 4, 2003, Pages 741-758

  Leuschner, Ulrich ^a  

^a GOETHE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; ANTINUCLEAR ANTIBODY; BILIRUBIN; GAMMA GLUTAMYLTRANSFERASE; GLYCOPROTEIN GP 120; IMMUNOGLOBULIN G; MITOCHONDRION ANTIBODY;

ABDOMINAL PAIN; ANTIBODY TITER; ARTHROPATHY; AUTOIMMUNE HEPATITIS; BILIRUBIN BLOOD LEVEL; DISEASE COURSE; FATIGUE; FEMALE; HASHIMOTO DISEASE; HEPATOMEGALY; HUMAN; INTRAHEPATIC CHOLESTASIS; JAUNDICE; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER HISTOLOGY; LIVER TRANSPLANTATION; MALE; PRIMARY BILIARY CIRRHOSIS; PROGNOSIS; PRURITUS; REVIEW; SJOEGREN SYNDROME; SPLENOMEGALY; SYNDROME CREST;

EID: 0141960203     PISSN: 10893261     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1089-3261(03)00101-6     Document Type: Review

References (86)

1. Addison T, Gull W. On a certain affection of the skin, vitiligoidea - a plana, b tuberosa. Guy's Hosp Rep 1851;7:265-76.
2. Rubin E, Schaffner F, Popper H. Primary biliary cirrhosis: chronic non-suppurative destructive cholangitis. Am J Pathol 1965;46:387-407.
3. Mitchison HC, Lucey MR, Kelly PJ, et al. Symptom development and prognosis in primary biliary cirrhosis: a study in two centers. Gastroenterology 1990;99:778-84.
4. Balasumbramaniam K, Grambsch PM, Wiesner RH, et al. Diminished survival in asymptomatic primary biliary cirrhosis: a prospective study. Gastroenterology 1990;98:1567-71.
5. Rydning A, Schrumpf E, Abdelnoor M, et al. Factors of prognostic importance in primary biliary cirrhosis. Scand J Gastroenterol 1990;25:119-26.
6. Metcalf JV, Mitchison HC, Palmer JM, et al. Natural history of early primary biliary cirrhosis. Lancet 1996;348:1399-402.
7. Invernizzi P, Crosignani A, Battezzatti PM, et al. Comparison of the clinical features and clinical course of antimitochondrial antibody-positive and -negative primary biliary cirrhosis. Hepatology 1997;25:1090-5.
8. Eriksson S, Lindgren S. The prevalence and clinical spectrum of primary biliary cirrhosis in a defined population. Scand J Gastroenterol 1984;19:971-6.
9. Kapelman B, Schaffner F. The natural history of primary biliary cirrhosis. Semin Liver Dis 1981;4:273-81.
10. Kim WR, Lindor KD, Locke III GR, et al. Epidemiology and natural history of primary biliary cirrhosis in a US community. Gastroenterology 2000;119:1631-6.
11. James OFW, Bhopal R, Howel D, et al. Primary biliary cirrhosis once rare now common in the United Kingdom? Hepatology 1999;30:390-4.
12. Sherlock S. Primary biliary cirrhosis/chronic intrahepatic obstructive jaundice. Gastroenterology 1959;37:574-86.
13. Tornay Jr AS. Primary biliary cirrhosis: natural history. Am J Gastroenterol 1980;73:223-6.
14. Uddenfeldt P, Danielsson A. Primary biliary cirrhosis: survival of a cohort followed for 10 years. J Intern Med 2000;248:292-8.
15. Ahrens Jr EH, Payne MA, Kunkel HG, et al. Primary biliary cirrhosis. Medicine 1950;29:299-364.
16. Hoffbauer FW. Primary biliary cirrhosis. Observations on the natural course of the disease in 25 women. Am J Dig Dis 1960;5:348-83.
17. Bloomer JR, Allen RM, Klatskin G. Serum bile acids in primary biliary cirrhosis. Arch Intern Med 1976;136:57-61.
18. Nyberg A, Loof L. Primary biliary cirrhosis: clinical features and outcome with special reference to asymptomatic disease. Scand J Gastroenterol 1989;24:57-64.
19. Sherlock S, Scheuer PJ. The presentation and diagnosis of 100 patients with primary biliary cirrhosis. N Engl J Med 1973;289:674-8.
20. Witt-Sullivan H, Heathcote J, Cauch K, et al. The demography of primary biliary cirrhosis in Ontario, Canada. Hepatology 1990;12:98-105.
21. Goldblatt J, Taylor PJS, Lipman T, et al. The true impact of fatigue in primary biliary cirrhosis: a population study. Gastroenterology 2002;122:1235-41.
22. Christensen E, Crowe J, Doniach D, et al. Clinical pattern and course of disease in primary biliary cirrhosis based on an analysis of 236 patients. Gastroenterology 1980;78:236-46.
23. Crowe J, Christensen E, Doniach D, et al. Early features of primary biliary cirrhosis: an analysis of 85 patients. Am J Gastroenterol 1985;80:466-8.
24. James O, Macklon AF, Watson A. Primay biliary cirrhosis - a revised clinical spectrum. Lancet June 1981;13:1278-81.
25. James OFW. Definition and epidemiology of primary biliary cirrhosis. In: Neuberger J, editor. Primary biliary cirrhosis. Eastbourne (UK): West End Studios Ltd.; 2000. p. 53-9.
26. Prince MI, James OFW, Holland NP, et al. Validation of a fatigue impact score in primary biliary cirrhosis: towards a standard for clinical and trial use. J Hepatol 2000;32:368-73.
27. Huet PM, Deslauriers J. Impact of fatigue on quality of life in patients with primary biliary cirrhosis. Gastroenterology 1996;110:A1215.
28. Cauch-Dudek K, Abbey S, Stewart DE, et al. Fatigue in primary biliary cirrhosis. Gut 1998;43:705-10.
29. Fisk J, Ritvo P, Ross L, et al. Measuring the functional impact of fatigue: initial validation of the Fatigue Impact Scale. Clin Infect Dis 1994;18:S79-83.
30. Cauch-Dudek K, Heathcote E, Hutere N, et al. Is disturbed sleep, based on objective polysomnographic indicators, a factor in the fatigue of patients with primary biliary cirrhosis? Hepatology 1998;28:A543.
31. Foster GR, Goldin RD, Thomas HC. Chronic hepatitis C infection causes a significant reduction in quality of life in the absence of cirrhosis. Hepatology 1998;27:209-12.
32. Talwalker J, Keach J, Angulo P, et al. Health related quality of life assessment in nonalcoholic steatohepatitis. Hepatology 2001;34:251A.
33. Gleeson D, Boyer J. Intrahepatic cholestasis. In: McIntyre N, Benhamou J-P, Bircher J, et al, editors. Oxford textbook of clinical hepatology. New York: Oxford University Press; 1991. p. 1087-107.
34. Ghent CN. Cholestatic pruritus. In: Bernhard JD, editor. Itch mechanisms and management of pruritus. New York: McGraw-Hill Inc.; 1994. p. 229-42.
35. Elias E, Burra P. Primary biliary cirrhosis: symptomatic treatment. J Gastroenterol Hepatol 1991;6:570-3.
36. Jones EA, Bergasa NV. The pruritus of cholestasis: evolving pathogenic concepts and therapeutic options. In: Manns MP, Boyer JL, Jansen PLM, et al, editors. Cholestatic liver diseases. London: Kluwer Academic Publishers; 1998. p. 248-60.
37. Reynolds TB. The butterfly sign in patients with chronic jaundice and pruritus. Ann Intern Med 1973;78:545-6.
38. Mahl TC, Schockcor W, Bayer JL. Primary biliary cirrhosis: survival of a large cohort of symptomatic and asymptomatic patients followed for 24 years. J Hepatol 1994;20:707-13.
39. Hodgson SF, Dickson ER, Wahner HW, et al. Bone loss and reduced osteoblast function in primary biliary cirrhosis. Ann Intern Med 1985;103:855-60.
40. Lucey MR, Neuberger JM, Williams R. Primary biliary cirrhosis in man. Gut 1986;27:1373-6.
41. Thomas PK, Walker JG. Xanthomatous neuropathy in primary biliary cirrhosis. Brain 1965;88:1079-88.
42. Schaffner F. Paradoxical elevation of serum cholesterol by clofibrate in patients with primary biliary cirrhosis. Gastroenterology 1969;57:253-5.
43. Roll J, Boyer JL, Barry D, et al. The prognostic importance of clinical and histological features in asymptomatic and syptomatic primary biliary cirrhosis. N Engl J Med 1983;308:1-7.
44. Nakanuma Y, Ohta G. Nodular hyperplasia of the liver in primary biliary cirrhosis of early histological stages. Am J Gastroenterol 1987;82:8-10.
45. Scheuer PJ. Pathologic features and evolution of primary biliary cirrhosis and primary sclerosing cholangitis. Mayo Clin Proc 1988;73:179-83.
46. Kew MC, Varma RR, Don Santos HA, et al. Portal hypertension in primary biliary cirrhosis. Gut 1971;12:830-4.
47. Navasa M, Pares A, Bruguera M, et al. Portal hypertension in primary biliary cirrhosis. J Hepatol 1987;5:292-8.
48. Huet PM, Huet J, Deslauriers J. Portal hypertension in patients with primary biliary cirrhosis. In: Lindor KD, Heathcote EJ, Poupon R, editors. Primary biliary cirrhosis: from pathogenesis to clinical treatment. London: Kluwer Academic Publishers; 1998. p. 87-91.
49. Gores GJ, Wiesner RH, Dickson ER, et al. Prospective evaluation of esophageal varices in primary biliary cirrhosis: development, natural history, and influence on survival. Gastroenterology 1988;96:1552-9.
50. Lindor KD, Jorgensen R, Dickson ER. Ursodeoxycholic acid delays the onset of esophageal varices in primary biliary cirrhosis. Hepatology 1996;22:125A.
51. Eastell R, Dickson ER, Hodgson SF, et al. Rates of vertebral loss before and after liver transplantation in women with primary biliary cirrhosis. Hepatology 1991;14:296-300.
52. Hay JE. Bone disease in cholestatic liver disease. Gastroenterology 1995;108:276-83.
53. Menon KVN, Angulo P, Weston S, et al. Bone disease in primary biliary cirrhosis. J Hepatol 2001;35:316-23.
54. Bagur A, Mantalen C, Findor J, et al. Risk factors for the development of vertebral and total skeleton osteoporosis in patients with primary biliary cirrhosis. Calcif Tissue Int 1998;63:385-90.
55. Lindenthal B, Leuschner MS, Ackermann H, et al. Is primary biliary cirrhosis (PBC) in itself a risk factor for osteoporosis? Hepatology 2000;32:168A.
56. Mitchison HC, Malcolm AJ, Bassendine MF, et al. Metabolic bone disease in primary biliary cirrhosis at presentation. Gastroenterology 1988;94:463-70.
57. Newton J, Francis R, Prince M, et al. Osteoporosis in primary biliary cirrhosis revisited. Gut 2001;49:282-7.
58. Compston JE, Thompson RPH. Intestinal absorption of 25-hydroxyvitamin D and osteomalacia in primary biliary cirrhosis. Lancet 1977;1:721-4.
59. Kehayoglou AK, Holdsworth CD, Agnew JE, et al. Bone disease and calcium absorption in primary biliary cirrhosis. Lancet 1968;1:715-9.
60. Guañabens N, Parés A, Mariñoso L, et al. Factors influencing the development of metabolic bone disease in primary biliary cirrhosis. Am J Gastroenterol 1990;85:1356-62.
61. Lindor KD, Janes CH, Crippin JS, et al. Bone disease in primary biliary cirrhosis: does ursodeoxycholic acid make a difference? Hepatology 1995;21:389-92.
62. De Bac C, Stroffolini T, Gaeta GB, et al. Pathogenic factors in cirrhosis with and without hepatocellular carcinoma. Hepatology 1994;20:1225-30.
63. Kaczynski J, Hansson G, Wallerstedt S. Incidence of primary cancer and aetiological aspects: a study of a defined population from a low-endemicity area. Br J Cancer 1996;73:1225-9.
64. Jones DEJ, Metcalf JV, Collier JD, et al. Hepatocellular carcinoma in primary biliary cirrhosis and its impact on outcome. Hepatology 1997;26:1138-42.
65. Shibuya A, Tanaka K, Miyakawa H, et al. Hepatocellular carcinoma and survival in patients with primary biliary cirrhosis. Hepatology 2002;35:1172-8.
66. Floreani A, Bavagiotta A, Baldo V, et al. Hepatic and extrahepatic malignancies in primary biliary cirrhosis. Hepatology 1999;29:1425-8.
67. Bush A, Mitchison H, Walt R, et al. Primary biliary cirrhosis and ulcerative colitis. Gastroenterology 1987;92:2009-13.
68. Kato Y, Marimoto H, Nmoura M, et al. Primary biliary cirrhosis and chronic pancreatitis in a patient with ulcerative colitis. J Clin Gastroenterol 1985;7:425-7.
69. Lever E, Balasumbramaniam K, Condon S, et al. Primary biliary cirrhosis associated with ulcerative colitis. Am J Gastroenterol 1993;88:943-7.
70. Rubel LR, Rabin L, Seeff LF, et al. Does primary biliary cirrhosis in men differ from primary biliary cirrhosis in women? Hepatology 1984;4:671-7.
71. Czaja AJ, Carpenter HA, Santrach PJ, et al. Autoimmune cholangitis with the spectrum of autoimmune liver disease. Hepatology 2000;31:1231-8.
72. Czaja AJ. The variant forms of autoimmune hepatitis. Ann Intern Med 1996;125:588-98.
73. Woodward J, Neuberger J. Autoimmune overlap syndromes. Hepatology 2001;33:994-1002.
74. Dahlan YM, Smith L, Simmonds D, et al. Pediatric onset primary biliary cirrhosis. Hepatology 2001;34:369A.
75. Berg PA, Klein R. Mitochondrial antigen/antibody systems in primary biliary cirrhosis: revisited. Liver 1995;15:281-92.
76. Kim WR, Poterucha JJ, Jorgensen RA, et al. Does antimitochondrial antibody status affect response to treatment in patients with primary biliary cirrhosis? Outcomes of ursodeoxycholic acid therapy and liver transplantation. Hepatology 1997;26:22-6.
77. Mitchison HC, Bassendine M, Hendrick A. Positive antimitochondrial antibody but normal alkaline phosphatase: is this primary biliary cirrhosis? Hepatology 1986;6:1279-84.
78. Van Norstrand M, Malinchoc M, Lindor K, et al. Quantitative measurement of autoantibodies to recombinant mitochondrial antigens in patients with primary biliary cirrhosis: relationship of levels of autoantibodies to disease progression. Hepatology 1997;25:6-11.
79. Lunettig B, Boeker K, Schoessler W, et al. The antinuclear autoantibodies Sp 100 and gp 210 persist after orthotopic liver transplantation in patients with primary biliary cirrhosis. J Hepatol 1998;28:824-8.
80. Yamazaki K, Nakamura A, Abe S, et al. Disappearance of antimitochondrial antibody in primary biliary cirrhosis during long-term ursodeoxycholic acid treatment. Gastroenterology 1996;110:A1364.
81. Itoh S, Ischida T, Yoshida T, et al. Autoantibodies against a 210 kDa glycoprotein of the nuclear pore complex as a prognostic marker in patients with primary biliary cirrhosis. J Gastro Hepatol 1998;13:257-65.
82. Krzeski P, Zych W, Kraszewska E, et al. Is serum bilirubin concentration the only valid prognostic marker in primary biliary cirrhosis? Hepatology 1999;30:865-9.
83. Poupon R, Chazouillères O, Balkau B, et al. Clinical and biochemical expression of the histopathological lesions of primary biliary cirrhosis. J Hepatol 1999;30:408-12.
84. Hübscher SG. Histological classification of autoimmune cholestatic liver diseases. In: Manns MP, Paumgartner G, Leuschner U, editors. Immunology and liver. London: Kluwer Academic Publishers; 2000. p. 223-43.
85. Leuschner U. Ursodeoxycholic acid therapy in primary biliary cirrhosis. Scand J Gastroenterol 1994;29(Suppl 204):40-6.
86. Chazouillères O, Wendum D, Serfaty L, et al. Primary biliary cirrhosis-autoimmune hepatitis overlap syndrome: clinical features and response to therapy. Hepatology 1998;28:296-301.